Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “The Regents of the University of Colorado”

401 pharma patents match "The Regents of the University of Colorado" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 401
Index total 30,257
Page 2 / 17

Quick answer

This filtered view shows 401 pharmaceutical patents matching "The Regents of the University of Colorado" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

401 results for “The Regents of the University of Colorado” · 30,257 patents in full index Clear search

  1. US 12109224

    USB1 directed regulation of miRNAs related hematopoietic differentiation and affected in multiple forms of leukemia

    The Regents of the University of Colorado, a Body Corporate · Granted Oct 8, 2024 · Expires Oct 3, 2044

    granted
  2. US 12097291

    Thermostable vaccine compositions and methods of preparing same

    The Regents of the University of Colorado, a Body Corporate · Granted Sep 24, 2024 · Expires Sep 19, 2044

    granted
  3. US 12084468

    Synthesis of backbone modified morpholino oligonucleotides and chimeras using phosphoramidite chemistry

    The Regents of the University of Colorado, a Body Corporate · Granted Sep 10, 2024 · Expires Sep 5, 2044

    granted
  4. US 12054607

    Tough, healable composites displaying stress relaxation at the resin-filler interface

    The Regents of the University of Colorado, a Body Corporate · Granted Aug 6, 2024 · Expires Aug 1, 2044

    granted
  5. US 12042529

    Optimization of enzyme replacement therapy for treatment of homocystinuria

    The Regents of the University of Colorado, a Body Corporate · Granted Jul 23, 2024 · Expires Jul 18, 2044

    granted
  6. US 12043601

    N-substituted-1H-1,2,4-triazole-3-carboxamides, analogues thereof, and methods of treatment using same

    The Regents of the University of Colorado · Granted Jul 23, 2024 · Expires Jul 18, 2044

    granted
  7. US 12030911

    Synthesis and biological activity of phosphoramidimidate and phosphoramidate DNA

    The Regents of the University of Colorado, a Body Corporate · Granted Jul 9, 2024 · Expires Jul 4, 2044

    granted
  8. US 12029732

    Treatment of vascular and lymphatic disease

    The Regents of the University of Colorado, a Body Corporate · Granted Jul 9, 2024 · Expires Jul 4, 2044

    granted
  9. US 12030958

    Compositions and methods of use of alpha-1 antitrypsin fusion polypeptides

    The Regents of the University of Colorado · Granted Jul 9, 2024 · Expires Jul 4, 2044

    granted
  10. US 12018081

    Photoconjugation reactions for modification of specific proteins on live cells

    The Regents of the University of Colorado, a Body Corporate · Granted Jun 25, 2024 · Expires Jun 20, 2044

    granted
  11. US 12011390

    Lacrimal drug delivery device

    The Regents of the University of Colorado, a Body Corporate · Granted Jun 18, 2024 · Expires Jun 13, 2044

    granted
  12. US 11993638

    GM-CSF mimetics and methods of making and using same

    The Regents of the University of Colorado, a Body Corporate · Granted May 28, 2024 · Expires May 23, 2044

    granted
  13. US 11981760

    Therapeutic hydrogels and contact lens for corneal melting

    The Regents of the University of Colorado, a Body Corporate · Granted May 14, 2024 · Expires May 9, 2044

    granted
  14. US 11974730

    Minimally-invasive measurement of esophageal inflammation

    The Regents of the University of Colorado · Granted May 7, 2024 · Expires May 2, 2044

    granted
  15. US 11964985

    Anti-cancer compounds targeting Ral GTPases and methods of using the same

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 23, 2024 · Expires Apr 18, 2044

    granted
  16. US 11957737

    Methods of treating microbial infection and inflammation

    The Regents of the University of Colorado · Granted Apr 16, 2024 · Expires Apr 11, 2044

    granted
  17. US 11933781

    Fibrosis model and methods of use thereof

    The Regents of the University of Colorado · Granted Mar 19, 2024 · Expires Mar 14, 2044

    granted
  18. US 11932867

    Methods of treating rheumatoid arthritis using RNA-guided genome editing of HLA gene

    The Regents of the University of Colorado, a Body Corporate · Granted Mar 19, 2024 · Expires Mar 14, 2044

    granted
  19. US 11911376

    Methods for preventing and treating retinal damage

    The Regents of the University of Colorado · Granted Feb 27, 2024 · Expires Feb 22, 2044

    granted
  20. US 11903952

    Vitamin D as an immune modulator to prevent immune-related complication from COVID-19 infection

    The Regents of the University of Colorado · Granted Feb 20, 2024 · Expires Feb 15, 2044

    granted
  21. US 11904007

    Protection from stress, anxiety, neuroinflammation, and cognitive dysfunction

    The Regents of the University of Colorado, a Body Corporate · Granted Feb 20, 2024 · Expires Feb 15, 2044

    granted
  22. US 11851436

    Fused bicyclic pyrimidine derivatives and uses thereof

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 26, 2023 · Expires Dec 21, 2043

    granted
  23. US 11833172

    Use of microRNA-146A and nanoceria conjugate to improve wound healing and promote tissue regeneration

    The Regents of the University of Colorado · Granted Dec 5, 2023 · Expires Nov 30, 2043

    granted
  24. US 11806432

    Compositions, methods and uses for thermally stable multi-targeted antigens

    The Regents of the University of Colorado, a Body Corporate · Granted Nov 7, 2023 · Expires Nov 2, 2043

    granted